301 Route 17 North
Suite 800
Rutherford, NJ 07070
United States
201 842 7715
https://glucotrack.com
Settore/i: Healthcare
Settore: Medical Instruments & Supplies
Impiegati a tempo pieno: 6
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Paul V. Goode Ph.D. | Chief Executive Officer | 225k | N/D | 1969 |
Mr. Mark Tapsak Ph.D. | Vice President of Technology | 165k | N/D | 1969 |
Ms. Drinda Benjamin | Vice President of Marketing | N/D | N/D | 1976 |
Mr. James P. Thrower Ph.D. | Vice President of Engineering | 230k | N/D | 1970 |
Mr. Avner Gal MBA, MSc.EE | Co-Founder, Chairman Emeritus, Consultant and Member of Scientific & Clinical Advisory Board | 187,39k | N/D | 1954 |
Mr. David Malka BA | Co-Founder | 191,86k | N/D | 1965 |
Mr. James S. Cardwell | Chief Financial Officer | N/D | N/D | 1961 |
GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
L'ISS Governance QualityScore di GlucoTrack, Inc. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.